Skip to main content
Giving to UC Davis Health System

Giving to UC Davis Health System

NEWS | February 17, 2012

UC Davis ophthalmology professor to deliver keynote lecture at glaucoma society meeting

(SACRAMENTO, Calif.)

James D. Brandt, professor of ophthalmology and vision science and director of the Glaucoma Service at the UC Davis Eye Center, will deliver the Clinician-Scientist Lecture at the 22nd annual meeting of the American Glaucoma Society on March 3 in New York.

His talk, entitled "Is it real or is it artifact  - what the cornea can tell us about glaucoma," will summarize nearly two decades of research on the role of central corneal thickness in the diagnosis of glaucoma.

As a principal investigator of the Ocular Hypertension Treatment Study, a $40 million National Eye Institute clinical trial focused on early prevention and treatments for glaucoma, Brandt spearheaded the identification of central corneal thickness as an independent risk factor for glaucoma. Today, that measure is recognized as an important predictor for glaucoma, and central corneal thickness and the genes that control it are new targets for understanding the biology of glaucoma, the second-eading cause of blindness worldwide.

Brandt also focuses on infantile and pediatric glaucomas and conducts research on the material properties of the eye as they affect the measurement of intraocular pressure and in the physiology of outflow resistance. He is currently collaborating with researchers in the fields of nanotechnology and biomedical engineering to develop new methods to measure outflow resistance in the living human eye.

The mission of the American Glaucoma Society is to promote excellence in the care of patients with glaucoma and preserve or enhance vision by supporting glaucoma specialists and scientists through the advancement of education and research. Established in 1985, the society has more than 800 members from 17 countries.

The UC Davis Eye Center aims to be the world's transformational leader in collaborative vision research and in the development of cures for blinding eye diseases from cornea to cortex.

UC Davis Health System is improving lives and transforming health care by providing excellent patient care, conducting groundbreaking research, fostering innovative, interprofessional education, and creating dynamic, productive partnerships with the community. The academic health system includes one of the country's best medical schools, a 631-bed acute-care teaching hospital, an 800-member physician's practice group and the new Betty Irene Moore School of Nursing. It is home to a National Cancer Institute-designated cancer center, an international neurodevelopmental institute, a stem cell institute and a comprehensive children's hospital. Other nationally prominent centers focus on advancing telemedicine, improving vascular care, eliminating health disparities and translating research findings into new treatments for patients. Together, they make UC Davis a hub of innovation that is transforming health for all. For more information, visit healthsystem.ucdavis.edu.